Compliance Corner: How To Survive An FDA ‘Desk Audit’ During The COVID-19 Crisis

A former US FDA investigations branch director explains how a paper-based “desk audit” would be performed by the agency in lieu of an on-site quality systems inspection. Last month the FDA hit the pause button on in-person inspections as the coronavirus pandemic rolls on.